“How do they do that?” is a reasonable response to certain things we see in nature. Pythons and snakes like them can eat prey as big as they are, sometimes even bigger, and digest their massive single ...

FDA's Adam Fisher speaks at the 2026 REdI meeting. (Source: REdI) Adam Fisher, the staff director of the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research (CDER) at the ...

The FDA has approved AstraZeneca’s Baxfendy to treat uncontrolled hypertension, marking the first approval for an aldosterone synthase inhibitor in the indication. Baxfendy, also known as baxdrostat, ...

Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.

The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...

Eli Lilly LLY1.86%increase; up pointing triangle Chief Executive Dave Ricks was on stage with Nvidia NVDA-1.39%decrease; down pointing triangle founder Jensen Huang earlier this year in San Francisco ...

The Trump administration is proposing wastewater testing on a national level to try to ferret out data on illegal drug use in real time, according to a draft of a new drug control strategy obtained by ...

The Justice Department reclassified marijuana from Schedule I to Schedule III as soon as April 22, according to a source. The shift does not legalize marijuana but could cut punitive taxes and expand ...

President Donald Trump’s claims about prescription drug prices make no mathematical sense. But his team – including Health Secretary Robert F. Kennedy Jr. this week – keeps straining to defend them.

WASHINGTON (AP) — President Donald Trump's acting attorney general on Thursday signed an order reclassifying state-licensed medical marijuana as a less-dangerous drug, a major policy shift long sought ...

The Trump administration on Thursday announced that it was loosening restrictions on marijuana to boost medical research, days after President Donald Trump appeared to express frustration with the ...